See Full Document Text
GOVERNMENT OF INDIA
MINISTRY OF AYUSH
LOK SABHA
UNSTARRED QUESTION NO. 1030
TO BE ANSWERED ON 24th JULY 2026
Upgradation of State Drug Testing Laboratories under AOGUSY
1030. Shri Brijmohan Agrawal:
Will the Minister of AYUSH be pleased to state:
(a) the total amount of funds allocated, released and utilised for upgrading State Drug Testing
Laboratories (DTLs) under the AYUSH Oushadhi Gunvatta Evam Uttpadan Samvardhan
Yojana (AOGUSY) during 2025-26, State/UT-wise;
(b) whether the Government has received any report regarding shortage of contractual staff in
the Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H) and
State Licensing Authorities resulting in delays in processing Form 25D application on the
e-Aushadhi Portal WHO-CoPP certifications under Schedule-T, if so, the details thereof;
(c) the details of the specific shortfall of AYUSH Drug Inspectors and Drug Testing
Laboratory (DTL) infrastructure in Chhattisgarh and its detrimental impact on herbal
Micro, Small and Medium Enterprises (MSMEs) and tribal Minor Forest Produce gatherers
in the Aspirational Districts; and
(d) the details of the corrective actions proposed including creation of a permanent central
regulatory cadre, 100% central funding for Drug Testing Laboratory (DTL) high-end
equipment and decentralizing WHO-CoPP audits to Central Drugs Standard Control
Organisation (CDSCO) zonal offices?
ANSWER
THE MINISTER OF STATE (IC) OF THE MINISTRY OF AYUSH
(SHRI PRATAPRAO JADHAV)
(a) During financial year 2025-26, 03 State Drug Testing Laboratories (DTLs) have been
supported financially under the Ayush Oushadhi Gunavatta evam Uttpadan Samvardhan Yojana
(AOGUSY) scheme. The details of total amount of funds allocated, released and utilised for
1upgrading State DTLs under the AOGUSY scheme during 2025-26, State/UT-wise are attached
at Annexure.
(b) There is no such report available with the ministry regarding shortage of contractual staff in
the Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H). Further, as
reported by State Licensing Authorities, there is no acute shortage of contractual staff.
However, WHO Certificate of Pharmaceutical Product (WHO-CoPP) to Ayush drugs is issued
by Central Drugs Standard Control Organization (CDSCO). Further e-Aushadhi portal (www.e-
aushadhi.gov.in) is being implemented by Ministry of Ayush for all Licensing related activities
of Ayush drugs to improve transparency, reduce processing delays and facilitate real-time
monitoring of applications and certifications. Respective State/UT Licensing Authorities can
issue license to the manufacturers to manufacture for sale of Ayurveda, Siddha, Sowa-Rigpa,
Unani and Homoeopathy medicines through e-Aushadhi portal as per the provisions of the Drugs
and Cosmetics Act, 1940 and Drugs Rules, 1945.
(c) As reported by the State Govt. of Chhattisgarh, there are 34 Ayush Drug Inspectors available
in Chhattisgarh, while the State has one Drug Testing Laboratory (DTL) in Raipur with the
requisite testing facilities. There is no specific shortfall in manpower and DTL infrastructure.
The Ministry of Ayush is regularly coordinating with the State Government and other concerned
stakeholders to strengthen the regulatory and drug testing ecosystem in the State, including the
Aspirational Districts.
(d) Ministry of Ayush is implementing the central sector scheme namely, Ayush Oushadhi
Gunavatta evam Uttpadan Samvardhan Yojana (AOGUSY), which provides 100% grant-in-aid
for upgrading and strengthening State/UT DTL including procurement and upgradation of high-
end analytical equipment. An Ayush vertical has been established in Central Drugs Standard
Control Organization (CDSCO) to strengthen regulatory measures ensuring safety and quality of
Ayush drugs. As per the existing guidelines, WHO Certificate of Pharmaceutical Product (WHO-
CoPP) to Ayush drugs is issued by Central Drugs Standard Control Organization (CDSCO) after
joint inspections of manufacturing units by Drug Inspectors posted in Ayush vertical along with
drug inspectors of State/UTs and CDSCO for compliance with WHO Technical Report Series
(TRS) guidelines for Herbal Medicines.
2Annexure
The details of total amount of funds allocated, released and utilised for upgrading State DTLs
under the AOGUSY during 2025-26, State/UT-wise are as follows-
• Amount Allocated under GIA head of the AOGUSY (for upgrading DTLs and
Pharmacies) during 2025-26 is Rs 17.50 Crore.
• Amount of funds released and utilised for upgrading State DTLs is as mentioned below-
(Amount in Rs)
S. State Component Govt./P Partic Total Amount Amount Expendit
No. vt./PSU ulars amount Released Released ure
Sanctioned in in 2025- incurred
previous 26 2025-26
years
1. Arunachal Strengthenin Govt. State 53,24,026 2023-24 17,99,813 17,99,813
Pradesh g and up- Govt.
17,99,813
gradation of DTL
Ayush
2024-25
Pharmacies
17,24,400
and Drug
Testing
2. Mizoram Govt. State 1,60,61,384 2021-22- 18,00,000 14,19,928
Laboratories
Govt. 18,00,000
to achieve
DTL
higher 2023-24
standards 67,20,884
2024-25
57,40,500
3. Madhya Govt. State 75,83,262 - 75,83,262 -
Pradesh Govt.
DTL
*****
3